U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07122284) titled 'Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity' on Aug. 06.
Brief Summary: Patients with concurrent Helicobacter pylori infection and small intestinal bacterial overgrowth (SIBO) represent a clinically challenging subgroup, often experiencing refractory gastrointestinal symptoms and diminished treatment responses. Current evidence indicates that individuals infected with H. pylori may related SIBO as a comorbidity; however, the synergistic effects of these conditions on gut ecosystem homeostasis remain poorly understood. To address this knowledge gap, we employed a dual-omics approach that combined shotgun metagen...